The HDAC3–SMARCA4–miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma

Overview of attention for article published in Science Signaling, November 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 4 news stories from 4 outlets.

@media screen and (max-device-width: 480px){body{ font-size:30pt !important;}} HACKENSACK, NJ / ACCESSWIRE / December 17, 2018 /C…

/ Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end range of research and development technology solutions and…

/ Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end range of research and development technology solutions and…

HACKENSACK, NJ / ACCESSWIRE / December 17, 2018 / Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end range of…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.